Related Experiment Video

Updated: Jun 17, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

[Postinfarction cardiac remodeling--clinical consequences]

Łukasz Karpiński1, Maria Witkowska

  • 1Klinika Kardiologii Akademii Medycznej we Wrocławiu. futuredream@poczta.fm

Przeglad Lekarski
|January 2, 2010
PubMed

Insights

Despite advances in treatment, many myocardial infarction survivors develop adverse cardiac remodeling and left ventricular (LV) dilatation. This progression can lead to heart failure, necessitating new therapeutic strategies.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Pathophysiology

Context:

  • Myocardial infarction (MI) remains a leading cause of heart disease.
  • Despite current treatments, a significant percentage of patients experience unfavorable cardiac remodeling and left ventricular (LV) dilatation post-MI.
  • This remodeling process is linked to systolic and diastolic dysfunction, potentially leading to heart failure.

Purpose:

  • To review the current understanding of post-infarction cardiac remodeling.
  • To highlight the ongoing challenges in managing unfavorable remodeling after myocardial infarction.
  • To emphasize the need for novel therapeutic approaches to prevent or reverse cardiac remodeling and its consequences.

Summary:

  • Adverse cardiac remodeling, characterized by left ventricular (LV) dilatation, affects 20-30% of myocardial infarction (MI) survivors long-term.
  • This pathological process involves structural and functional changes, including myocardial dysfunction, and can precipitate heart failure.
  • Recent research increasingly suggests that LV remodeling may be reversible, driving the search for targeted interventions.

Impact:

  • Improved understanding of cardiac remodeling mechanisms post-MI.
  • Potential for developing new, specific therapies to counteract adverse remodeling.
  • Reduced incidence of heart failure in post-MI patients.
  • Enhanced long-term outcomes and quality of life for myocardial infarction survivors.

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...